{
  "docId": "019de076-8eed-77e6-97e7-f406514b962a",
  "docSlug": "e8bbfe027845ab55cba77860ad12e49b",
  "documentTitle": "Absci | Investor Conference Presentation Deck | 22 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 22,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8eed-77e6-97e7-f406514b962a/14",
  "deckHref": "/decks/019de076-8eed-77e6-97e7-f406514b962a",
  "deckJsonHref": "/decks/019de076-8eed-77e6-97e7-f406514b962a.json",
  "deckAnchorHref": "/decks/019de076-8eed-77e6-97e7-f406514b962a#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.41,
        "x": 0.05,
        "y": 0.0019
      },
      "kind": "image",
      "text": "AI-designed TL1A program designed to achieve superior therapeutic properties over clinical competitors",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62fd8847-7c44-4d8b-9035-c00841ccb069",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.51,
        "y": 0.0081
      },
      "kind": "list",
      "text": "DIFFERENTIATED INTELLECTUAL PROPERTY",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12de8098-e839-4ad2-b7be-10e91e25e9d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.45,
        "x": 0.51,
        "y": 0.004
      },
      "kind": "list",
      "text": "SUPERIOR PRE-CLINICAL PROFILE AND POTENTIAL FOR SUPERIOR CLINICAL PROFILE: High Affinity & Potency, Extended Half life & Longer Dosing Intervals (Q8W to once quarterly), Sub-Q Dosing (Low immunogenicity, High bioavailability), Favorable Developability",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbc94428-2980-4779-a1e3-433fd8dfa4e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.51,
        "y": 0.0024
      },
      "kind": "list",
      "text": "DE NOVO AI-DESIGNED AND AI-OPTIMIZED: Target to promising candidates in just over 1 year",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc1e9828-2c56-4e51-8915-7d7b3c9cf5aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.58,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "title",
      "text": "Potential Best-in-Class TL1A mAb Designed using Generative AI",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "349a1fbb-e091-4e65-89bf-83dd03edc767",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.38,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "ABS-101 TL1A DATA HIGHLIGHTS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2798b057-93a7-4fe4-946f-ec3fe75de1d8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "1e60ed5c-cb9e-45e7-bdb9-018af0ab5bf4",
      "evidence": "list/bullet: SUPERIOR PRE-CLINICAL PROFILE AND POTENTIAL FOR SUPERIOR CLINICAL PROFILE: High Affinity & Potency, Extended Half life & Longer Dosing Intervals (Q8W to once quarterly), Sub-Q Dosing (Low immunogenicity, Hig",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 7,
      "beatId": "f41652a3-0ce4-4c59-9eb5-afc4f0769e6c",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation showcases Absci's solution and its potential benefits.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}